Abstract:Abstract Abstract 4857 Background: Acute leukemia (AL) is a clonal hematopoietic stem cell disorder with diverse genetic abnormalities and various responses to treatment. AL was categorized into favorable, intermediate and adverse karyotype according to cytogenetic characteristics comprising different groups of patients with similar treatment response, relapse risk and overall survival. In particular, Patients with complex chromosome aberrations (CCA) harboring three or more acquired chromosome aberrations always have poor outcomes. It is necessary to investigate the clinical and laboratory features of AL patients with CCA, and to explore the underlying mechanisms of leukemogenesis in order to improve prognosis in these patients. Methods: 83 AL patients with CAA were investigated and other 83 AL patients with none-complex chromosome aberrations (N-CCA) were regarded as control group from January 2005 to August 2008. The diagnosis of AL was based on morphological picture, immunophenotypical analysis, and cytochemical studies and FAB criteria were used for AL subtype classifications. Karyotypes were also analysed using conventional G-banding method. After patients had comfirmed diagnosis with AL, corresponding induction and consolidation chemotherapy in the two groups were given. Finally the treatment efficacy and prognosis were assessed. All the statistical analyses were performed using Kaplan-Meier. Results: There was no significant difference about sex, age and peripheral blood parameters before treatment between AL patients with CAA and the control group during the same period (p>0.05). CD34 was expressed in 72.3% of the AL patients with CCA, significantly higher than that in the control group (37.4%)(p<0.01). CD34+ AL patients with CCA showed a lower complete remission (CR) rate than in CD34- cases (p<0.05). 3-years EFS and OS were shorter in CD34+ patients than in CD34- cases. Using Kaplan-Meier analysis, the median survival time of AL patients with CCA was only 9 months, significantly shorter than the control group (21.5 months). There was no significant difference between AML and ALL patients with complex chromosome aberrations about CR rate and the survive time. Conclusion: The prognosis of patients with complex karyotype who received chemotherapy was extremely poor. In view of this, such patients should be considered as a unique entity and separated from those with a non-complex adverse cytogenetic change. They maybe benefit to some extent from allogeneic stem cell transplantation in younger patients according to some related reports. CD34 was associated with CAA while the underlying mechanisms between them were unknown. Disclosures: No relevant conflicts of interest to declare.

Complex karyotypes confer a poor survival in adult acute myeloid leukemia with unfavorable cytogenetic abnormalities

[Analysis of Age-Specific Cytogenetic Changes among 515 Patients Withacute Myeloid Leukemia].

Karyotypic Analysis and Prognosis for 41 Patients with Chronic Myelomonocytic Leukemia

Analysis of the Karyotype Abnormalities and Its Prognostic in 298 Patients with Myelodysplastic Syndrome

Cytogenetic Abnormalities Predict Disease Progression in Primary Myelodysplastic Syndrome: A Multicentric Study in 508 Chinese Patients.

Analysis of Clinical and Molecular Features of MDS Patients with Complex Karyotype in China.

Cytogenetic Analysis of 1863 Chineses Patients with Chronic Myeloid Leukemia

Predictive Factors of Response and Survival Following Chemotherapy Treatment In Acute Leukemia with Complex Karyotype Aberrations

Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia

Clinical Characterization and Prognostic Factors of 144 Adult Acute Monocytic Leukemia

Prognostic Significance of Complex Karyotypes in Acute Myeloid Leukemia

Clinical Significance of Cytogenetic and Molecular Genetic Abnormalities in 634 Chinese Patients with Myelodysplastic Syndromes

Aging and Comprehensive Molecular Profiling in Acute Myeloid Leukemia.

Karyotype complexity and prognosis in acute myeloid leukemia

Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients

Clinical features of complex karyotype in newly diagnosed acute myeloid leukemia

The relationship between clinical feature, complex immunophenotype, chromosome karyotype, and outcome of patients with acute myeloid leukemia in China.

Correction: Chronic Myeloid Leukemia with Insertion-Derived BCR–ABL1 Fusion: Redefining Complex Chromosomal Abnormalities by Correlation of FISH and Karyotype Predicts Prognosis

Importance of assessing cytogenetic and molecular risk factors in acute myeloid leukemia therapy

Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

Clinical Analysis of Cytogenetic Features in Acute Myeloid Leukemia and Its Relationship with Early Responses after Induction Therapy